Green Valley Investors’s AbbVie ABBV Stock Holding History

Green Valley Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000,000	Closed	-$67.2M	–	28
2015 Q2	$67.2M	Sell	1,000,000 -1,680,000	-63%	-$110M	1.29%	24
2015 Q1	$157M	Hold	2,680,000	–	–	3.15%	16
2014 Q4	$175M	Hold	2,680,000	–	–	3.69%	10
2014 Q3	$155M	Hold	2,680,000	–	–	3.54%	11
2014 Q2	$151M	Hold	2,680,000	–	–	3.52%	12
2014 Q1	$138M	Hold	2,680,000	–	–	3.16%	14
2013 Q4	$142M	Hold	2,680,000	–	–	3.09%	15
2013 Q3	$120M	Hold	2,680,000	–	–	2.95%	16
2013 Q2	$111M	Buy	+2,680,000	New	+$117M	2.71%	17

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Green Valley Investors's ABBV Position: Q3 2015 in Review

Green Valley Investors sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 1,000,000 shares — an estimated $67.2M sold.

Green Valley Investors first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $175M in Q4 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Green Valley Investors reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
Green Valley Investors sold 1,000,000 AbbVie shares in Q3 2015, an estimated $67.2M.
Green Valley Investors first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
Green Valley Investors's AbbVie position peaked at $175M in Q4 2014.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Green Valley Investors's 13F filing for Q3 2015, filed 12 Nov 2015.